Clinical Trial Update: ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using antithymocyte globulin for prophylaxis of acute graft-versus-host disease in haploidentical hematopoietic stem cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Antithymocyte Globulin (anti-thymocyte globulin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Hematopoietic Stem Cell Transplantation, Antithymocyte Globulin | Phase 4 | Status: COMPLETED